-
公开(公告)号:WO2007081517A8
公开(公告)日:2007-09-20
申请号:PCT/US2006048685
申请日:2006-12-20
Applicant: ABBOTT LAB , BETEBENNER DAVID A , DEGOEY DAVID A , MARING CLARENCE J , KRUEGER ALLAN C , IWASAKI NOBUHIKO , ROCKWAY TODD W , COOPER CURT S , ANDERSON DAVID D , DONNER PAMELA L , GREEN BRIAN E , KEMPF DALE J , LIU DACHUN , MCDANIEL KEITH F , MADIGAN DAROLD L , MOTTER CHRISTOPHER E , PRATT JOHN K , SHANLEY JASON P , TUFANO MICHAEL D , WAGNER ROLF , ZHANG RONG , MOLLA AKHTERUZZAMAN , MO HONGMEI , PILOT-MATIAS TAMI J , MASSE SHERIE VL , CARRICK ROBERT J , HE WEPING , LU LIANGJUN , GRAMPOVNIK DAVID J
Inventor: BETEBENNER DAVID A , DEGOEY DAVID A , MARING CLARENCE J , KRUEGER ALLAN C , IWASAKI NOBUHIKO , ROCKWAY TODD W , COOPER CURT S , ANDERSON DAVID D , DONNER PAMELA L , GREEN BRIAN E , KEMPF DALE J , LIU DACHUN , MCDANIEL KEITH F , MADIGAN DAROLD L , MOTTER CHRISTOPHER E , PRATT JOHN K , SHANLEY JASON P , TUFANO MICHAEL D , WAGNER ROLF , ZHANG RONG , MOLLA AKHTERUZZAMAN , MO HONGMEI , PILOT-MATIAS TAMI J , MASSE SHERIE VL , CARRICK ROBERT J , HE WEPING , LU LIANGJUN , GRAMPOVNIK DAVID J
IPC: C07D495/04 , C07D471/04 , C07D513/04
CPC classification number: C07D487/04 , C07D471/04 , C07D475/06 , C07D495/04 , C07D513/04
Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abstract translation: 公开了有效抑制丙型肝炎病毒(“HCV”)或其他病毒复制的化合物。 本发明还涉及包含这些化合物的组合物,这些化合物与其它抗病毒剂或治疗剂的共同配制或共同给药,用于合成这些化合物的方法和中间体,以及使用这些化合物治疗 HCV或其他病毒感染。
-
公开(公告)号:WO2007076035A3
公开(公告)日:2007-07-05
申请号:PCT/US2006/049080
申请日:2006-12-20
Applicant: ABBOTT LABORATORIES , ROCKWAY, Todd, W. , BETEBENNER, David, A. , KRUEGER, Allan, C. , IWASAKI, Nobuhiko , COOPER, Curt, S. , ANDERSON, David, D. , KEMPF, Dale, J. , MADIGAN, Darold, L. , MOTTER, Christopher, E. , SHANLEY, Jason, P. , TUFANO, Michael, D. , WAGNER, Rolf , ZHANG, Rong , MOLLA, Akhteruzzaman , MO, Hongmei , PILOT-MATIAS, Tami , MASSE, Sherie, VL. , CARRICK, Robert, J. , HE, Weping , LU, Liangjun
Inventor: ROCKWAY, Todd, W. , BETEBENNER, David, A. , KRUEGER, Allan, C. , IWASAKI, Nobuhiko , COOPER, Curt, S. , ANDERSON, David, D. , KEMPF, Dale, J. , MADIGAN, Darold, L. , MOTTER, Christopher, E. , SHANLEY, Jason, P. , TUFANO, Michael, D. , WAGNER, Rolf , ZHANG, Rong , MOLLA, Akhteruzzaman , MO, Hongmei , PILOT-MATIAS, Tami , MASSE, Sherie, VL. , CARRICK, Robert, J. , HE, Weping , LU, Liangjun
IPC: C07D471/04
Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
-
公开(公告)号:WO2007076035A2
公开(公告)日:2007-07-05
申请号:PCT/US2006049080
申请日:2006-12-20
Applicant: ABBOTT LAB , ROCKWAY TODD W , BETEBENNER DAVID A , KRUEGER ALLAN C , IWASAKI NOBUHIKO , COOPER CURT S , ANDERSON DAVID D , KEMPF DALE J , MADIGAN DAROLD L , MOTTER CHRISTOPHER E , SHANLEY JASON P , TUFANO MICHAEL D , WAGNER ROLF , ZHANG RONG , MOLLA AKHTERUZZAMAN , MO HONGMEI , PILOT-MATIAS TAMI , MASSE SHERIE VL , CARRICK ROBERT J , HE WEPING , LU LIANGJUN
Inventor: ROCKWAY TODD W , BETEBENNER DAVID A , KRUEGER ALLAN C , IWASAKI NOBUHIKO , COOPER CURT S , ANDERSON DAVID D , KEMPF DALE J , MADIGAN DAROLD L , MOTTER CHRISTOPHER E , SHANLEY JASON P , TUFANO MICHAEL D , WAGNER ROLF , ZHANG RONG , MOLLA AKHTERUZZAMAN , MO HONGMEI , PILOT-MATIAS TAMI , MASSE SHERIE VL , CARRICK ROBERT J , HE WEPING , LU LIANGJUN
IPC: C07D471/04
CPC classification number: C07D471/04
Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abstract translation: 公开了有效抑制丙型肝炎病毒(“HCV”)或其他病毒复制的化合物。 本发明还涉及包含此类化合物的组合物,此类化合物与其他抗病毒剂或治疗剂的共同配制或共同施用,用于合成此类化合物的方法和中间体,以及使用此类化合物治疗 HCV或其他病毒感染。
-
公开(公告)号:WO2007076034A2
公开(公告)日:2007-07-05
申请号:PCT/US2006/049079
申请日:2006-12-20
Applicant: ABBOTT LABORATORIES , BETEBENNER, David, A. , DEGOEY, David, A. , MARING, Clarence, J. , KRUEGER, Allan, C. , IWASAKI, Nobuhiko , ROCKWAY, Todd, W. , COOPER, Curt, S. , ANDERSON, David, D. , DONNER, Pamela, L. , GREEN, Brian, E. , KEMPF, Dale, J. , LIU, Dachun , MCDANIEL, Keith, F. , MADIGAN, Darold, L. , MOTTER, Christopher, E. , PRATT, John, K. , SHANLEY, Jason, P. , TUFANO, Michael, D. , WAGNER, Rolf , ZHANG, Rong , MOLLA, Akhteruzzaman , MO, Hongmei , PILOT-MATIAS, Tami, J. , MASSE, Sherie, VL. , CARRICK, Robert, J. , HE, Weping , LU, Liangjun , GRAMPOVNIK, David, J.
Inventor: BETEBENNER, David, A. , DEGOEY, David, A. , MARING, Clarence, J. , KRUEGER, Allan, C. , IWASAKI, Nobuhiko , ROCKWAY, Todd, W. , COOPER, Curt, S. , ANDERSON, David, D. , DONNER, Pamela, L. , GREEN, Brian, E. , KEMPF, Dale, J. , LIU, Dachun , MCDANIEL, Keith, F. , MADIGAN, Darold, L. , MOTTER, Christopher, E. , PRATT, John, K. , SHANLEY, Jason, P. , TUFANO, Michael, D. , WAGNER, Rolf , ZHANG, Rong , MOLLA, Akhteruzzaman , MO, Hongmei , PILOT-MATIAS, Tami, J. , MASSE, Sherie, VL. , CARRICK, Robert, J. , HE, Weping , LU, Liangjun , GRAMPOVNIK, David, J.
IPC: C07D471/04
CPC classification number: C07D471/04 , C07D495/04 , C07D513/04
Abstract: Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abstract translation: 公开了有效抑制丙型肝炎病毒(“HCV”)或其它病毒复制的化合物。 本发明还涉及包含此类化合物的组合物,此类化合物与其他抗病毒剂或治疗剂的共同配制或共同施用,用于合成此类化合物的方法和中间体,以及使用此类化合物治疗 HCV或其他病毒感染。 p>
-
公开(公告)号:WO2005019191A2
公开(公告)日:2005-03-03
申请号:PCT/US2004/027000
申请日:2004-08-19
Applicant: ABBOTT LABORATORIES , HUTCHINSON, Douglas, K. , BELLETTINI, John, R. , BETEBENNER, David, A. , BISHOP, Richard, D. , BORCHARDT, Thomas, B. , BOSSE, Todd, D. , CINK, Russell, D. , FLENTGE, Charles, A. , GATES, Bradley, D. , GREEN, Brian, E. , HINMAN, Mira, M. , HUANG, Peggy, P. , KLEIN, Larry, L. , KRUEGER, Allan, C. , LARSON, Daniel, P. , LEANNA, M., Robert , LIU, Dachun , MADIGAN, Darold, L. , MCDANIEL, Keith, F. , RANDOLPH, John, T. , ROCKWAY, Todd, W. , ROSENBERG, Teresa, A. , STEWART, Kent, D. , STOLL, Vincent, S. , WAGNER, Rolf , YEUNG, Ming, C.
Inventor: HUTCHINSON, Douglas, K. , BELLETTINI, John, R. , BETEBENNER, David, A. , BISHOP, Richard, D. , BORCHARDT, Thomas, B. , BOSSE, Todd, D. , CINK, Russell, D. , FLENTGE, Charles, A. , GATES, Bradley, D. , GREEN, Brian, E. , HINMAN, Mira, M. , HUANG, Peggy, P. , KLEIN, Larry, L. , KRUEGER, Allan, C. , LARSON, Daniel, P. , LEANNA, M., Robert , LIU, Dachun , MADIGAN, Darold, L. , MCDANIEL, Keith, F. , RANDOLPH, John, T. , ROCKWAY, Todd, W. , ROSENBERG, Teresa, A. , STEWART, Kent, D. , STOLL, Vincent, S. , WAGNER, Rolf , YEUNG, Ming, C.
IPC: C07D285/00
CPC classification number: C07D417/12 , C07D285/24 , C07D285/30 , C07D513/04
Abstract: Compounds having the formula (I) are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.
Abstract translation: 具有式(I)的化合物是丙型肝炎(HCV)聚合酶抑制剂。 还公开了用于抑制丙型肝炎(HCV)聚合酶的组合物和方法,用于制备化合物的方法和在该方法中使用的合成中间体。
-
-
-
-